Medical Countermeasures for Chemical, Biological, Radiological and Nuclear (CBRN) Threats - R&D Funding

This invite-only funding opportunity supports the research and development of medical solutions to protect against chemical, biological, radiological, and nuclear threats. Eligible projects include novel therapeutics, medical devices, diagnostics, and other medical interventions at various development stages: from prototype development through laboratory testing to early-phase human trials (up to Phase 2a). Your project must clearly demonstrate how it will strengthen the UK's preparedness and response capabilities for CBRN incidents. Maximum funding available is £4 million (80% full economic cost), with projects running for up to 30 months. This is an invitation-only scheme, so you must be selected to apply.